MP-101

· Marathon Pharmaceuticals, LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MP-101, covering 2015-02-18 to 2021-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression [Phase 2]